Option Care Health expects up to a $70 million revenue hit in 2025 from Stelara pricing changes and biosimilar adoption, ...

What Happened: JR demonstrated confidence in Option Care Health by purchasing 38,000 shares, as reported in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday. The total value ...

Alternate site health provider Option Care Health (NASDAQ:OPCH) reported Q3 CY2025 results , with sales up 12.2% year on year ...

Fintel reports that on November 3, 2025, TD Cowen maintained coverage of Option Care Health (NasdaqGS:OPCH) with a Hold ...

Shares of alternate site health provider Option Care Health (NASDAQ:OPCH) jumped 3.2% in the afternoon session after Morgan Stanley initiated coverage on the stock with an 'Overweight' rating and a ...

During the last three months, 7 analysts shared their evaluations of Option Care Health (NASDAQ:OPCH), revealing diverse outlooks from bullish to bearish. The table below summarizes their recent ...

6 analysts have expressed a variety of opinions on Option Care Health (NASDAQ:OPCH) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below provides a ...

Option Care Health (OPCH) stock is on the radar as investors look at how recent returns compare with the company’s long-term performance. Short-term gains have contrasted with losses seen over the ...

John C. Rademacher, CEO, stated that Option Care Health delivered "another strong quarter with balanced growth across the portfolio" and is increasing guidance for the year across revenue, adjusted ...

Orion Portfolio Solutions LLC decreased its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 4.3% during the fourth quarter, HoldingsChannel.com reports. The institutional ...

Option Care Health, the largest alternative infusion provider, is poised to benefit from the shift to home-based health and the growing specialty pharmaceuticals market. Despite the 13% drop YTD, OPCH ...

Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, will participate in the following upcoming ...